Seeing Is Believing
Healthcare - Sector
PLX is currently covered by 1 analysts with an average price target of $12. This is a potential upside of $9.41 (363.32%) from yesterday's end of day stock price of $2.59.
Protalix Biotherapeutics's activity chart (see below) currently has 15 price targets and 15 ratings on display. The stock rating distribution of PLX is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 12.22% with an average time for these price targets to be met of 52 days.
Highest price target for PLX is $12, Lowest price target is $12, average price target is $12.
Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 09-Sep-2026. First documented stock forecast 09-Nov-2012.
Currently out of the existing stock ratings of PLX, 3 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 04-Apr-2016
$12
$9.41 (363.32%)
1 months 23 days ago
(09-Sep-2026)
0/8 (0%)
$9.33 (349.44%)
Buy Since 23-Apr-2015
$21
$18.41 (710.81%)
$17.5
9 years 13 days ago
(19-Oct-2017)
1/5 (20%)
$13.19 (168.89%)
14
What is PLX (Protalix Biotherapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on PLX (Protalix Biotherapeutics)?
Which analyst has the most public recommendations on PLX (Protalix Biotherapeutics)?
Which analyst is the currently most bullish on PLX (Protalix Biotherapeutics)?
Which analyst is the currently most reserved on PLX (Protalix Biotherapeutics)?